Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Telerx Acquires Sentrx Safety Solutions | Contract Pharma

What are you searching for?

Sign in
Breaking News

Telerx Acquires Sentrx Safety Solutions

Adds drug safety services

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Telerx has acquired Sentrx Safety Solutions, a provider of pharmacovigilance outsourcing services, expanding its pharma/healthcare business unit. Telerx will retain Sentrx’s approximately 100 employees and executive leadership team.
 
“The pharmaceutical and healthcare industries are undergoing unprecedented change and specialized services such as those provided by Telerx will grow in importance as entities within these industries work to meet new regulations,” said Linda Schellenger, president of Telerx. “We are confident that our acquisition of Sentrx will position us for faster growth and enable us to better serve the needs of our clients.”
 
Michael O’Gorman, chief executive officer of Sentrx, said, “All of us at Sentrx are excited to be part of Telerx. By integrating our services and technologies with a company which has been successful in the healthcare space over the past 33 years, we will be able to more competitively offer the most comprehensive portfolio of services to a wide range of pharmaceutical companies and healthcare providers.”
 
Fairmount partners introduced the two companies and advised both of them under separate deal terms.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters